Analysis Of Income And Expense [Abstract]

Transgene - Filing #2816866

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
9 993 EUR
2 981 EUR
Material income and expense [abstract]
Research and development expense
32 883 EUR
27 346 EUR
Selling, general and administrative expense [abstract]
General and administrative expense
7 369 EUR
6 547 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
19 536 EUR
372,000 EUR
 -  EUR
 -  EUR
 -  EUR
19 908 EUR
19 908 EUR
 -  EUR
 -  EUR
 -  EUR
17 224 EUR
 -  EUR
17 224 EUR
17 231 EUR
7,000 EUR
 -  EUR
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
 -  EUR
 -  EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.